CLRB (Cellectar Biosciences INC NEW) Stock Analysis - Analyst Ratings

Cellectar Biosciences INC NEW (CLRB) is a publicly traded Healthcare sector company. As of May 21, 2026, CLRB trades at $3.10 with a market cap of $25.09M and a P/E ratio of -0.38. CLRB moved +3.43% today. Year to date, CLRB is -5.37%; over the trailing twelve months it is -59.97%. Its 52-week range spans $2.43 to $67.50. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces CLRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CLRB?

3 analysts cover CLRB: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $10.33.

CLRB Key Metrics

Key financial metrics for CLRB
MetricValue
Price$3.10
Market Cap$25.09M
P/E Ratio-0.38
EPS$-8.35
Dividend Yield0.00%
52-Week High$67.50
52-Week Low$2.43
Volume2.25K
Avg Volume0
Revenue (TTM)$0
Net Income$-21.79M
Gross Margin0.00%

CLRB Analyst Consensus

3 analysts cover CLRB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.33.

Latest CLRB News

Recent CLRB Insider Trades

  • Longcor Jarrod bought 8.68K (~$25.00K) on May 7, 2026.
  • CARUSO JAMES V bought 8.68K (~$25.00K) on May 7, 2026.
  • NEIS JOHN sold 198 (~$731.986) on Dec 12, 2025.

Common questions about CLRB

What do analysts rate CLRB?
3 analysts cover CLRB: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $10.33.
Does Rallies show CLRB price targets?
Yes. Rallies tracks CLRB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CLRB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLRB. It does not provide personalized investment advice.
CLRB

CLRB